Identification of cell surface targets for HIV-1 therapeutics using genetic screens

Virology

Volumn 321, Issue 2, 2004, Pages 260-273

  Dunn, Stephen J ^a,c   Khan, Imran H ^b   Chan, Ursula A ^a   Scearce, Robin L ^a   Melara, Claudia L ^a,d   Paul, Amber M ^a,e   Sharma, Vikram ^a,f   Bih, Fong Yih ^a   Holzmayer, Tanya A ^a   Luciw, Paul A ^b   Abo, Arie ^a  

^a Pharmaceutical Product Development   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Hybridoma Department ^*  (United States)

^d Medarex Inc   (United States)

^e ROCHE BIOSCIENCE   (United States)

^f IntegriGen Inc   (United States)

Author keywords

Cell surface targets; Genetic suppressor element; HIV

Indexed keywords

ANTIINFECTIVE AGENT; CD47 ANTIGEN; CD69 ANTIGEN; CELL SURFACE PROTEIN; CHEMOKINE RECEPTOR CCR4; CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CXCR4; CHLORDANE; COMPLEMENTARY DNA; ENFUVIRTIDE; GLYCOPROTEIN P 15095; HERMES ANTIGEN; PROTEIN; PROTEIN CD74; PROTEIN CSFR 3; PROTEIN GABBR 1; RNA; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2; UNCLASSIFIED DRUG; VIRUS DNA; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CONTROLLED STUDY; DNA LIBRARY; DNA SYNTHESIS; DRUG TARGETING; GENE FUNCTION; GENE IDENTIFICATION; GENE REPRESSION; GENE SEQUENCE; GENE TARGETING; GENETIC SCREENING; HOST CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIFE CYCLE; MOLECULAR RECOGNITION; NONHUMAN; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA INTERFERENCE; TARGET CELL; VIRUS STRAIN;

ANIMALS; ANTI-HIV AGENTS; ANTIGENS, CD; CELL LINE; GENE EXPRESSION REGULATION, VIRAL; GENE TARGETING; GENES, SUPPRESSOR; HIV-1; HUMANS; LEUKOCYTES, MONONUCLEAR; MEMBRANE PROTEINS; RECEPTORS, CELL SURFACE; RECEPTORS, VIRUS; RNA, SMALL INTERFERING; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 12144290390     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virol.2004.01.010     Document Type: Article

References (86)

1. Afonina E., Neumann M., Pavlakis G.N. Preferential binding of poly(A)-binding protein 1 to an inhibitory RNA element in the human immunodeficiency virus type 1 gag mRNA. J. Biol. Chem. 272:1997;2307-2311.
2. Agrawal L., Alkhatib G. Chemokine receptors: emerging opportunities for new anti-HIV therapies. Expert Opin. Ther. Targets. 5:2001;303-326.
3. Agrawal L., Vanhorn-Ali Z., Alkhatib G. Multiple determinants are involved in HIV coreceptor use as demonstrated by CCR4/CCL22 interaction in peripheral blood mononuclear cells (PBMCs). J. Leukocyte. Biol. 72:2002;1063-1074.
4. Ambrosino C., Ruocco M.R., Chen X., Mallardo M., Baudi F., Trematerra S., Quinto I., Venuta S., Scala G. HIV-1 Tat induces the expression of the interleukin-6 (IL6) gene by binding to the IL6 leader RNA and by interacting with CAAT enhancer-binding protein beta (NF-IL6) transcription factors. J. Biol. Chem. 272:1997;14883-14892.
5. Avalos B.R. Molecular analysis of the granulocyte colony-stimulating factor receptor. Blood. 88:1996;761-777.
6. Berger E.A., Murphy P.M., Farber J.M. Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. Annu. Rev. Immunol. 17:1999;657-700.
7. Blazquez M.V., Macho A., Ortiz C., Lucena C., Lopez-Cabrera M., Sanchez-Madrid F., Munoz E. Extracellular HIV type 1 tat protein induces CD69 expression through NF-kappaB activation: possible correlation with cell surface tat-binding proteins. AIDS Res. Hum. Retroviruses. 15:1999;1209-1218.
8. Bleul C.C., Farzan M., Choe H., Parolin C., Clark-Lewis I., Sodroski J., Springer T.A. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 activity. Nature. 382:1996;829-833.
9. Brown E.J., Frazier W.A. Integrin-associated protein (CD47) and its ligands. Trends Cell Biol. 11:2001;130-135.
10. Caputi M., Mayeda A., Krainer A.R., Zahler A.M. hnRNP A/B proteins are required for inhibition of HIV-1 pre-mRNA splicing. EMBO J. 18:1999;4060-4067.
11. Cimarelli A., Luban J. Translation elongation factor 1-alpha interacts specifically with human immunodeficiency virus type 1 Gag polyprotein. J. Virol. 73:1999;5388-5401.
12. Clapham P.R., McKnight A. HIV-1 receptors and cell tropism. Br. Med. Bull. 58:2001;43-59.
13. Clapham P.R., McKnight A. Cell surface receptors, virus entry and tropism of primate lentiviruses. J. Gen. Virol. 83:2002;1809-1829.
14. Corbeil J., Sheeter D., Genini D., Rought S., Leoni L., Du P., Ferguson M., Masys D.R., Welsh J.B., Fink J.L., Sasik R., Huang D., Drenkow J., Richman D.D., Gingeras T. Temporal gene regulation during HIV-1 infection of human CD4+T cells. Genome Res. 11:2001;1198-1204.
15. Corbi A.L., Lopez-Rodriguez C. CD11c integrin gene promoter activity during myeloid differentiation. Leuk. Lymphoma. 25:1997;415-425.
16. Cresswell P. Assembly, transport, and function of MHC class II molecules. Annu. Rev. Immunol. 12:1994;259-293.
17. Davis C.B., Dikic I., Unutmaz D., Hill C.M., Arthos J., Siani M.A., Thompson D.A., Schlessinger J., Littman D.R. Signal transduction due to HIV-1 envelope interactions with chemokine receptors CXCR4 or CCR5. J. Exp. Med. 186:1997;1793-1798.
18. de la Fuente C., Santiago F., Deng L., Eadie C., Zilberman I., Kehn K., Maddukuri A., Baylor S., Wu K., Lee C.G., Pumfery A., Kashanchi F. Gene expression profile of HIV-1 Tat expressing cells: a close interplay between proliferative and differentiation signals. BMC Biochem. 3:2002;14.
19. Desire N., Dehee A., Schneider V., Jacomet C., Goujon C., Girard P.M., Rozenbaum W., Nicolas J.C. Quantification of human immunodeficiency virus type 1 proviral load by a TaqMan real-time PCR assay. J. Clin. Microbiol. 39:2002;1303-1310.
20. Diatchenko L., Lau Y.F., Campbell A.P., Chenchik A., Moqadam F., Huang B., Lukyanov S., Lukyanov K., Gurskaya N., Sverdlov E.D., Siebert P.D. Suppression subtractive hybridization: a method for generating differentially regulated or tissue-specific cDNA probes and libraries. Proc. Natl. Acad. Sci. U.S.A. 93:1996;6025-6030.
21. Dunn S.J., Park S.W., Sharma V., Raghu G., Simone J.M., Tavassoli R., Young L.M., Ortega M.A., Pan C.H., Alegre G.J., Roninson I.B., Lipkina G., Dayn A., Holzmayer T.A. Isolation of efficient antivirals: genetic suppressor elements against HIV-1. Gene Ther. 6:1999;130-137.
22. El Messaoudi K., Thiry L.F., Liesnard C., Van Tieghem N., Bollen A., Moguilevsky N. A human milk factor susceptible to cathepsin D inhibitors enhances human immunodeficiency virus type 1 infectivity and allows virus entry into a mammary epithelial cell line. J. Virol. 74:2000;1004-1007.
23. Faulkner N.E., Lane B.R., Bock P.J., Markovitz D.M. Protein phosphatase 2A enhances activation of human immunodeficiency virus type 1 by phorbol myristate acetate. J. Virol. 77:2003;2276-2281.
24. Fujinaga K., Cujec T.P., Peng J., Garriga J., Price D.H., Grana X., Peterlin B.M. The ability of positive transcription elongation factor B to transactivate human immunodeficiency virus transcription depends on a functional kinase domain, cyclin T1, and Tat. J. Virol. 72:1998;7154-7159.
25. Fukushi M., Dixon J., Kimura T., Tsurutani N., Dixon M.J., Yamamoto N. Identification and cloning of a novel cellular protein Naf1, Nef-associated factor 1, that increases cell surface CD4 expression. FEBS Lett. 442:1999;83-88.
26. Furman P.A., Barry D.W. Spectrum of antiviral activity and mechanism of action of zidovudine. An overview. Am. J. Med. 85:1988;176-181.
27. Gallagher W.M., Cairney M., Schott B., Roninson I.B., Brown R. Identification of p53 genetic suppressor elements which confer resistance to cisplatin. Oncogene. 14:1997;185-193.
28. ING1 promotes neoplastic transformation. Nat. Genet. 14:1996;415-420.
29. Garrus J.E., von Schwedler U.K., Pornillos O.W., Morham S.G., Zavitz K.H., Wang H.E., Wettstein D.A., Stray K.M., Cote M., Rich R.L., Myszka D.G., Sundquist W.I. Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding. Cell. 107:2001;55-65.
30. Geiss G.K., Bumgarner R.E., An M.C., Agy M.B., van 't Wout A.B., Hammersmark E., Carter V.S., Upchurch D., Mullins J.I., Katze M.G. Large-scale monitoring of host cell gene expression during HIV-1 infection using cDNA microarrays. Virology. 266:2000;8-16.
31. Goodison S., Urquidi V., Tarin D. CD44 cell adhesion molecules. Mol. Pathol. 52:1999;189-196.
32. Gudkov A.V., Roninson I.B. Isolation of genetic suppressor elements (GSEs) from random fragment cDNA libraries in retroviral vectors. Cowell I.G., Austin C.A. cDNA Protocols. Methods Mol. Biol. vol. 69:1996;221-340 Human Press, Totowa, NJ.
33. Gudkov A.V., Zelnick C.R., Kazarov A.R., Thimmapaya R., Suttle D.P., Beck W.T., Roninson I.B. Isolation of genetic suppressor elements, inducing resistance to topoisomerase II-interactive cytotoxic drugs, from human topoisomerase II cDNA. Proc. Natl. Acad. Sci. U.S.A. 90:1993;3231-3235.
34. Gudkov A.V., Kazarov A.R., Thimmapaya R., Axenovich S.A., Mazo I.A., Roninson I.B. Cloning mammalian genes by expression selection of genetic suppressor elements: association of kinesin with drug resistance and immortalization. Proc. Natl. Acad. Sci. U.S.A. 91:1994;3744-3748.
35. Hioe C.E., Bastiani L., Hildreth J.E., Zolla-Pazner S. Role of cellular adhesion molecules in HIV type 1 infection and their impact on virus neutralization. AIDS Res. Hum. Retroviruses. 14:1998;S247-S254.
36. Hoffman T.L., Doms R.W. Chemokines and coreceptors in HIV/SIV-host interactions. AIDS. 12:1998;S17-S26.
37. Holness C.L., Simmons D.L. Molecular cloning of CD68, a human macrophage marker related to lysosomal glycoproteins. Blood. 81:1993;1607-1613.
38. Holzmayer T.A., Pestov D.G., Roninson I.B. Isolation of dominant negative mutants and inhibitory antisense RNA sequences by expression selection of random DNA fragments. Nucleic Acids Res. 20:1992;711-717.
39. Kilby J.M., Hopkins S., Venetta T.M., DiMassimo B., Cloud G.A., Lee J.Y., Alldredge L., Hunter E., Lambert D., Bolognesi D., Matthews T., Johnson M.R., Nowak M.A., Shaw G.M., Saag M.S. Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry. Nat. Med. 4:1998;1302-1307.
40. Lama J., Trono D. Human immunodeficiency virus type 1 matrix protein interacts with cellular protein HO3. J. Virol. 72:1998;1671-1676.
41. Lane B.R., Lore K., Bock P.J., Andersson J., Coffey M.J., Strieter R.M., Markovitz D.M. Interleukin-8 stimulates human immunodeficiency virus type 1 replication and is a potential new target for antiretroviral therapy. J. Virol. 75:2001;8195-8202.
42. Lesley J., Hyman R. CD44 structure and function. Front. Biosci. 3:1998;d616-d630.
43. Levenson V.V., Lausch E., Kirschling D.J., Broude E.V., Davidovich I.A., Libants S., Fedosova V., Roninson I.B. A combination of genetic suppressor elements produces resistance to drugs inhibiting DNA replication. Somatic Cell Mol. Genet. 25:1999;9-26.
44. Li J., Tang H., Mullen T.M., Westberg C., Reddy T.R., Rose D.W., Wong-Staal F. A role for RNA helicase A in post-transcriptional regulation of HIV type 1. Proc. Natl. Acad. Sci. U.S.A. 96:1999;709-714.
45. Littman D.R. Chemokine receptors: keys to AIDS pathogenesis? Cell. 93:1998;677-680.
46. Loetscher P., Moser B., Baggiolini M. Chemokines and their receptors in lymphocyte traffic and HIV infection. Adv. Immunol. 74:2000;127-180.
47. Lu X., Wu X., Plemenitas A., Yu H., Sawai E.T., Abo A., Peterlin B.M. CDC42 and Rac1 are implicated in the activation of the Nef-associated kinase and replication of HIV-1. Curr. Biol. 6:1996;1677-1684.
48. Mahalingam S., Ayyavoo V., Patel M., Kieber-Emmons T., Kao G.D., Muschel R.J., Weiner D.B. HIV-1 Vpr interacts with a human 34-kDa mov34 homologue, a cellular factor linked to the G2/M phase transition of the mammalian cell cycle. Proc. Natl. Acad. Sci. U.S.A. 95:1998;3419-3424.
49. Martinez M.A., Gutierrez A., Armand-Ugon M., Blanco J., Parera M., Gomez J., Clotet B., Este J.A. Suppression of chemokine receptor expression by RNA interference allows for inhibition of HIV-1 replication. AIDS. 16:2002;2385-2390.
50. Marzio R., Mauel J., Betz-Corradin S. CD69 and regulation of the immune function. Immunopharmacol. Immunotoxicol. 21:1999;565-582.
51. Miller A.D., Rosman G.J. Improved retroviral vectors for gene transfer and expression. BioTechniques. 7:1989;980-990.
52. Misse D., Cerutti M., Noraz N., Jourdan P., Favero J., Devauchelle G., Yssel H., Taylor N., Veas F. A CD4-independent interaction of human immunodeficiency virus-1 gp120 with CXCR4 induces their cointernalization, cell signaling, and T-cell chemotaxis. Blood. 93:1999;2454-2462.
53. Moore J.P., Stevenson M. New targets for inhibitors of HIV-1 replication. Nat. Rev., Mol. Cell Biol. 1:2000;40-49.
54. Nagira M., Sato A., Miki S., Imai T., Yoshie O. Enhanced HIV-1 replication by chemokines constitutively expressed in secondary lymphoid tissues. Virology. 264:1999;422-426.
55. Novina C.D., Murray M.F., Dykxhoorn D.M., Beresford P.J., Riess J., Lee S.K., Collman R.G., Lieberman J., Shankar P., Sharp P.A. siRNA-directed inhibition of HIV-1 infection. Nat. Med. 8:2002;681-686.
56. Novoa I., Zeng H., Harding H.P., Ron D. Feedback inhibition of the unfolded protein response by GADD34-mediated dephosphorylation of eIF2alpha. J. Cell Biol. 153:2001;1011-1022.
57. Oberlin E., Amara A., Bachelerie F., Bessia C., Virelizier J.L., Arenzana-Seisdedos F., Schwartz O., Heard J.M., Clark-Lewis I., Legler D.F., Loetscher M., Baggiolini M., Moser B. The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1. Nature. 382:1996;833-835.
58. O'Doherty U., Swiggard W.J., Malim M.H. Human immunodeficiency virus type 1 spinoculation enhances infection through virus binding. J. Virol. 74:2000;10074-10080.
59. Ohgimoto S., Tabata N., Suga S., Nishio M., Ohta H., Tsurudome M., Komada H., Kawano M., Watanabe N., Ito Y. Molecular characterization of fusion regulatory protein-1 (FRP-1) that induces multinucleated giant cell formation of monocytes and HIV gp160-mediated cell fusion. FRP-1 and 4F2/CD98 are identical molecules. J. Immunol. 155:1995;3585-3592.
60. Ong J., Kerr D.I. Recent advances in GABAB receptors: from pharmacology to molecular biology. Acta Pharmacol. Sin. 21:2000;111-123.
61. Ossovskaya V.S., Mazo I.A., Chernov M.V., Chernova O.B., Strezoska Z., Kondratov R., Stark G.R., Chumakov P.M., Gudkov A.V. Use of genetic suppressor elements to dissect distinct biological effects of separate p53 domains. Proc. Natl. Acad. Sci. U.S.A. 93:1996;10309-10314.
62. Ott D.E. Potential roles of cellular proteins in HIV-1. Rev. Med. Virol. 12:2002;359-374.
63. Owen S.M., Ellenberger D., Rayfield M., Wiktor S., Michel P., Grieco M.H., Gao F., Hahn B.H., Lal R.B. Genetically divergent strains of human immunodeficiency virus type 2 use multiple coreceptors for viral entry. J. Virol. 72:1998;5425-5432.
64. Pestov D.G., Lau L. Genetic selection of growth-inhibitory sequences in mammalian cells. Proc. Natl. Acad. Sci. U.S.A. 91:1994;12549-12553.
65. Power C.A., Meyer A., Nemeth K., Bacon K.B., Hoogewerf A.J., Proudfoot A.E., Wells T.N. Molecular cloning and functional expression of a novel CC chemokine receptor cDNA from a human basophilic cell line. J. Biol. Chem. 270:1995;19495-19500.
66. Primiano T., Baig M., Maliyekkel A., Chang B.D., Fellars S., Sadhu J., Axenovich S.A., Holzmayer T.A., Roninson I.B. Identification of potential anticancer drug targets through the selection of growth-inhibitory genetic suppressor elements. Cancer Cells. 4:2003;41-53.
67. Reddy T.R., Suhasini M., Rappaport J., Looney D.J., Kraus G., Wong-Staal F. Molecular cloning and characterization of a TAR-binding nuclear factor from T cells. AIDS Res. Hum. Retroviruses. 11:1995;663-669.
68. Reddy T.R., Tang H., Xu W., Wong-Staal F. Sam68, RNA helicase A and Tap cooperate in the post-transcriptional regulation of human immunodeficiency virus and type D retroviral mRNA. Oncogene. 19:2000;3570-3575.
69. Rimaniol A.C., Boussin F.D., Dormont D., Bach J.F., Zavala F. Mechanisms of downmodulation and release of tumour necrosis factor receptor induced by human immunodeficiency virus type 1 in human monocytes. Cytokine. 9:1997;9-18.
70. Rivadeneira E.D., Saul D.L., Yu Y., Haynes B.F., Weinberg J.B. Inhibition of HIV type 1 infection of mononuclear phagocytes by anti-CD44 antibodies. AIDS Res. Hum. Retroviruses. 11:1995;541-546.
71. Roscic-Mrkic B., Fischer M., Leemann C., Manrique A., Gordon C.J., Moore J.P., Proudfoot A.E., Trkola A. RANTES (CCL5) utilizes the proteoglycan CD44 as an auxiliary receptor to mediate cellular activation signals and HIV-1 enhancement. Blood. 102:2003;1169-1177.
72. Rossi F., Evstafieva A., Pedrali-Noy G., Gallina A., Milanesi G. HsN3 proteasomal subunit as a target for human immunodeficiency virus type 1 Nef protein. Virology. 237:1997;33-45.
73. Ruhl M., Himmelspach M., Bahr G.M., Hammerschmid F., Jaksche H., Wolff B., Aschauer H., Farrington G.K., Probst H., Bevec D., Hauber J. Eukaryotic initiation factor 5A is a cellular target of the human immunodeficiency virus type 1 Rev activation domain mediating trans-activation. J. Cell Biol. 123:1993;1309-1920.
74. Ryffel B., Mihatsch M.J. TNF receptor distribution in human tissues. Int. Rev. Exp. Pathol. 34:1993;149-156.
75. Ryo A., Suzuki Y., Arai M., Kondoh N., Wakatsuki T., Hada A., Shuda M., Tanaka K., Sato C., Yamamoto M., Yamamoto N. Identification and characterization of differentially expressed mRNAs in HIV type 1-infected human T cells. AIDS Res. Hum. Retroviruses. 16:2000;995-1005.
76. Stauber R.H., Rulong S., Palm G., Tarasova N.I. Direct visualization of HIV-1 entry: mechanisms and role of cell surface proteins. Biochem. Biophys. Res. Commun. 258:1999;695-702.
77. Surabhi R.M., Gaynor R.B. RNA interference directed against viral and cellular targets inhibits human immunodeficiency virus type 1 replication. J. Virol. 76:2002;12963-12973.
78. Truant R., Cullen B.R. The arginine-rich domains present in human immunodeficiency virus type 1 Tat and Rev function as direct importin beta-dependent nuclear localization signals. Mol. Cell. Biol. 19:1999;1210-1217.
79. Ugolini S., Mondor I., Sattentau Q.J. HIV-1 attachment: another look. Trends Microbiol. 7:1999;144-149.
80. +-T-cell lines. J. Virol. 77:2003;1392-1402.
81. Venkatesh L.K., Gettemeier T., Chinnadurai G. A nuclear kinesin-like protein interacts with and stimulates the activity of the leucine-rich nuclear export signal of the human immunodeficiency virus type 1 Rev protein. J. Virol. 77:2003;7236-7243.
82. Wasserman K., Subklewe M., Pothoff G., Banik N., Schell-Frederick E. Expression of surface markers on alveolar macrophages from symptomatic patients with HIV infection as detected by flow cytometry. Chest. 105:1994;1324-1334.
83. Withers-Ward E.S., Jowett J.B., Stewart S.A., Xie Y.M., Garfinkel A., Shibagaki Y., Chow S.A., Shah N., Hanaoka F., Sawitz D.G., Armstrong R.W., Souza L.M., Chen I.S. Human immunodeficiency virus type 1 Vpr interacts with HHR23A, a cellular protein implicated in nucleotide excision DNA repair. J. Virol. 71:1997;9732-9742.
84. Xiao H., Neuveut C., Benkirane M., Jeang K.T. Interaction of the second coding exon of Tat with human EF-1 delta delineates a mechanism for HIV-1-mediated shut-off of host mRNA translation. Biochem. Biophys. Res. Commun. 244:1998;384-389.
85. Yanagihara S., Komura E., Nagafune J., Watarai H., Yamaguchi Y. EBI1/ CCR7 is a new member of dendritic cell chemokine receptor that is up-regulated upon maturation. J. Immunol. 161:1998;3096-3102.
86. Yoshida R., Nagira M., Imai T., Baba M., Takagi S., Tabira Y., Akagi J., Nomiyama H., Yoshie O. EBI1-ligand chemokine (ELC) attracts a broad spectrum of lymphocytes: activated T cells strongly up-regulate CCR7 and efficiently migrate toward ELC. Int. Immunol. 10:1998;901-910.